<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2024//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_240101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">36569883</PMID><DateCompleted><Year>2022</Year><Month>12</Month><Day>27</Day></DateCompleted><DateRevised><Year>2023</Year><Month>01</Month><Day>18</Day></DateRevised><Article PubModel="Electronic-eCollection"><Journal><ISSN IssnType="Electronic">1664-3224</ISSN><JournalIssue CitedMedium="Internet"><Volume>13</Volume><PubDate><Year>2022</Year></PubDate></JournalIssue><Title>Frontiers in immunology</Title><ISOAbbreviation>Front Immunol</ISOAbbreviation></Journal><ArticleTitle>Omicron variants of SARS-CoV-2 and long COVID.</ArticleTitle><Pagination><StartPage>1061686</StartPage><MedlinePgn>1061686</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">1061686</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.3389/fimmu.2022.1061686</ELocationID><Abstract><AbstractText>Understanding the epidemiology of long COVID and emerging variants has significant public-health implications as physical interventions and restrictions that help limit viral spread are eased globally. Here, we provide rationales for the necessity of updating current vaccines to improve protection against omicron and emerging variants, as well as more research into understanding the epidemiology and mechanisms of long COVID.</AbstractText><CopyrightInformation>Copyright &#xa9; 2022 Yang, Zhao, Shannon and Tebbutt.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Yang</LastName><ForeName>Chengliang</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Prevention of Organ Failure (PROOF) Centre of Excellence, St. Paul's Hospital, University of British Columbia, Vancouver, BC, Canada.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Centre for Heart Lung Innovation, Providence Research, St. Paul's Hospital, Vancouver, BC, Canada.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Division of Respiratory Medicine, Department of Medicine, University of British Columbia, Vancouver, BC, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zhao</LastName><ForeName>Hedi</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>Department of Surgery, University of British Columbia, Vancouver, BC, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Shannon</LastName><ForeName>Casey P</ForeName><Initials>CP</Initials><AffiliationInfo><Affiliation>Prevention of Organ Failure (PROOF) Centre of Excellence, St. Paul's Hospital, University of British Columbia, Vancouver, BC, Canada.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Centre for Heart Lung Innovation, Providence Research, St. Paul's Hospital, Vancouver, BC, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Tebbutt</LastName><ForeName>Scott J</ForeName><Initials>SJ</Initials><AffiliationInfo><Affiliation>Prevention of Organ Failure (PROOF) Centre of Excellence, St. Paul's Hospital, University of British Columbia, Vancouver, BC, Canada.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Centre for Heart Lung Innovation, Providence Research, St. Paul's Hospital, Vancouver, BC, Canada.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Division of Respiratory Medicine, Department of Medicine, University of British Columbia, Vancouver, BC, Canada.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>177747</GrantID><Agency>CIHR</Agency><Country>Canada</Country></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2022</Year><Month>12</Month><Day>09</Day></ArticleDate></Article><MedlineJournalInfo><Country>Switzerland</Country><MedlineTA>Front Immunol</MedlineTA><NlmUniqueID>101560960</NlmUniqueID><ISSNLinking>1664-3224</ISSNLinking></MedlineJournalInfo><SupplMeshList><SupplMeshName Type="Organism" UI="C000711908">SARS-CoV-2 variants</SupplMeshName></SupplMeshList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000094024" MajorTopicYN="Y">Post-Acute COVID-19 Syndrome</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000086402" MajorTopicYN="N">SARS-CoV-2</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000086382" MajorTopicYN="Y">COVID-19</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011634" MajorTopicYN="N">Public Health</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">COVID-19</Keyword><Keyword MajorTopicYN="N">SARS-CoV-2</Keyword><Keyword MajorTopicYN="N">long covid</Keyword><Keyword MajorTopicYN="N">omicron variant</Keyword><Keyword MajorTopicYN="N">post COVID-19 condition</Keyword><Keyword MajorTopicYN="N">vaccine</Keyword></KeywordList><CoiStatement>The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2022</Year><Month>10</Month><Day>4</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2022</Year><Month>11</Month><Day>29</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2022</Year><Month>12</Month><Day>26</Day><Hour>4</Hour><Minute>24</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2022</Year><Month>12</Month><Day>27</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2022</Year><Month>12</Month><Day>28</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2022</Year><Month>12</Month><Day>9</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">36569883</ArticleId><ArticleId IdType="pmc">PMC9780375</ArticleId><ArticleId IdType="doi">10.3389/fimmu.2022.1061686</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Huang L, Yao Q, Gu X, Wang Q, Ren L, Wang Y, et al. . 1-year outcomes in hospital survivors with COVID-19: a longitudinal cohort study. Lancet (2021) 398:747&#x2013;58. doi: 10.1016/S0140-6736(21)01755-4</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(21)01755-4</ArticleId><ArticleId IdType="pmc">PMC8389999</ArticleId><ArticleId IdType="pubmed">34454673</ArticleId></ArticleIdList></Reference><Reference><Citation>Yang C, Zhao H, Tebbutt SJ. Long-term effects on survivors with COVID-19. Lancet (2021) 398:1872. doi: 10.1016/S0140-6736(21)02323-0</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(21)02323-0</ArticleId><ArticleId IdType="pmc">PMC8601683</ArticleId><ArticleId IdType="pubmed">34801103</ArticleId></ArticleIdList></Reference><Reference><Citation>Lopez-Leon S, Wegman-Ostrosky T, Perelman C, Sepulveda R, Rebolledo PA, Cuapio A, et al. . More than 50 long-term effects of COVID-19: a systematic review and meta-analysis. Sci Rep (2021) 11:16144. doi: 10.1038/s41598-021-95565-8</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41598-021-95565-8</ArticleId><ArticleId IdType="pmc">PMC8352980</ArticleId><ArticleId IdType="pubmed">34373540</ArticleId></ArticleIdList></Reference><Reference><Citation>Global Burden of Disease Long COVID Collaborators. Wulf Hanson S, Abbafati C, Aerts JG, Al-Aly Z, Ashbaugh C, et al. . Estimated global proportions of individuals with persistent fatigue, cognitive, and respiratory symptom clusters following symptomatic COVID-19 in 2020 and 2021. JAMA (2022) 328:1604&#x2013;15. doi: 10.1001/jama.2022.18931</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jama.2022.18931</ArticleId><ArticleId IdType="pmc">PMC9552043</ArticleId><ArticleId IdType="pubmed">36215063</ArticleId></ArticleIdList></Reference><Reference><Citation>Yang C, Zhao H, Tebbutt SJ. A glimpse into long COVID and symptoms. Lancet Respir Med (2022) 10:e81. doi: 10.1016/S2213-2600(22)00217-X</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S2213-2600(22)00217-X</ArticleId><ArticleId IdType="pmc">PMC9187332</ArticleId><ArticleId IdType="pubmed">35697054</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen C, Haupert SR, Zimmermann L, Shi X, Fritsche LG, Mukherjee B. Global prevalence of post COVID-19 condition or long COVID: A meta-analysis and systematic review. J Infect Dis (2022) 226:1593&#x2013;607. doi: 10.1093/infdis/jiac136</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/infdis/jiac136</ArticleId><ArticleId IdType="pmc">PMC9047189</ArticleId><ArticleId IdType="pubmed">35429399</ArticleId></ArticleIdList></Reference><Reference><Citation>
Office for National Statistics . Prevalence of ongoing symptoms following coronavirus (COVID-19) infection in the UK: 1 September 2022 (2022). Available at: https://www.ons.gov.uk/peoplepopulationandcommunity/healthandsocialcare/conditionsanddiseases/bulletins/prevalenceofongoingsymptomsfollowingcoronaviruscovid19infectionintheuk/1september2022 (Accessed September 16, 2022).</Citation></Reference><Reference><Citation>Pulliam JRC, van Schalkwyk C, Govender N, von Gottberg A, Cohen C, Groome MJ, et al. . Increased risk of SARS-CoV-2 reinfection associated with emergence of omicron in south Africa. Science (2022) 376:eabn4947. doi: 10.1126/science.abn4947</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.abn4947</ArticleId><ArticleId IdType="pmc">PMC8995029</ArticleId><ArticleId IdType="pubmed">35289632</ArticleId></ArticleIdList></Reference><Reference><Citation>Nyberg T, Ferguson NM, Nash SG, Webster HH, Flaxman S, Andrews N, et al. . Comparative analysis of the risks of hospitalisation and death associated with SARS-CoV-2 omicron (B.1.1.529) and delta (B.1.617.2) variants in England: A cohort study. Lancet (2022) 399:1303&#x2013;12. doi: 10.1016/S0140-6736(22)00462-7</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(22)00462-7</ArticleId><ArticleId IdType="pmc">PMC8926413</ArticleId><ArticleId IdType="pubmed">35305296</ArticleId></ArticleIdList></Reference><Reference><Citation>Murray CJL. COVID-19 will continue but the end of the pandemic is near. Lancet (2022) 399:417&#x2013;9. doi: 10.1016/S0140-6736(22)00100-3</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(22)00100-3</ArticleId><ArticleId IdType="pmc">PMC8769657</ArticleId><ArticleId IdType="pubmed">35065006</ArticleId></ArticleIdList></Reference><Reference><Citation>Phetsouphanh C, Darley DR, Wilson DB, Howe A, Munier CML, Patel SK, et al. . Immunological dysfunction persists for 8 months following initial mild-to-moderate SARS-CoV-2 infection. Nat Immunol (2022) 23:210&#x2013;6. doi: 10.1038/s41590-021-01113-x</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41590-021-01113-x</ArticleId><ArticleId IdType="pubmed">35027728</ArticleId></ArticleIdList></Reference><Reference><Citation>Naranbhai V, Nathan A, Kaseke C, Berrios C, Khatri A, Choi S, et al. . T Cell reactivity to the SARS-CoV-2 omicron variant is preserved in most but not all individuals. Cell (2022) 185:1041&#x2013;51. doi: 10.1016/j.cell.2022.01.029</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cell.2022.01.029</ArticleId><ArticleId IdType="pmc">PMC8810349</ArticleId><ArticleId IdType="pubmed">35202566</ArticleId></ArticleIdList></Reference><Reference><Citation>Mentzer AJ, O&#x2019;Connor D, Bibi S, Chelysheva I, Clutterbuck EA, Demissie T, et al. . Human leukocyte antigen alleles associate with COVID-19 vaccine immunogenicity and risk of breakthrough infection. Nat Med (2022). doi:&#xa0;10.1038/s41591-022-02078-6</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41591-022-02078-6</ArticleId><ArticleId IdType="pmc">PMC9873562</ArticleId><ArticleId IdType="pubmed">36228659</ArticleId></ArticleIdList></Reference><Reference><Citation>Antonelli M, Pujol JC, Spector TD, Ourselin S, Steves CJ. Risk of long COVID associated with delta versus omicron variants of SARS-CoV-2. Lancet (2022) 399:2263&#x2013;4. doi: 10.1016/S0140-6736(22)00941-2</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(22)00941-2</ArticleId><ArticleId IdType="pmc">PMC9212672</ArticleId><ArticleId IdType="pubmed">35717982</ArticleId></ArticleIdList></Reference><Reference><Citation>Al-Aly Z, Bowe B, Xie Y. Long COVID after breakthrough SARS-CoV-2 infection. Nat Med (2022) 28:1461&#x2013;7. doi: 10.1038/s41591-022-01840-0</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41591-022-01840-0</ArticleId><ArticleId IdType="pmc">PMC9307472</ArticleId><ArticleId IdType="pubmed">35614233</ArticleId></ArticleIdList></Reference><Reference><Citation>Kared H, Wolf AS, Alirezaylavasani A, Ravussin A, Solum G, Tran TT, et al. . Immune responses in omicron SARS-CoV-2 breakthrough infection in vaccinated adults. Nat Commun (2022) 13:4165. doi: 10.1038/s41467-022-31888-y</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41467-022-31888-y</ArticleId><ArticleId IdType="pmc">PMC9293966</ArticleId><ArticleId IdType="pubmed">35851055</ArticleId></ArticleIdList></Reference><Reference><Citation>Cao Y, Yisimayi A, Jian F, Song W, Xiao T, Wang L, et al. . BA.2.12.1, BA.4 and BA.5 escape antibodies elicited by omicron infection. Nature (2022) 608:593&#x2013;602. doi: 10.1038/s41586-022-04980-y</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41586-022-04980-y</ArticleId><ArticleId IdType="pmc">PMC9385493</ArticleId><ArticleId IdType="pubmed">35714668</ArticleId></ArticleIdList></Reference><Reference><Citation>Yao L, Zhu KL, Jiang XL, Wang XJ, Zhan BD, Gao HX, et al. . Omicron subvariants escape antibodies elicited by vaccination and BA.2.2 infection. Lancet Infect Dis (2022) 22:1116&#x2013;7. doi: 10.1016/S1473-3099(22)00410-8</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S1473-3099(22)00410-8</ArticleId><ArticleId IdType="pmc">PMC9212811</ArticleId><ArticleId IdType="pubmed">35738299</ArticleId></ArticleIdList></Reference><Reference><Citation>Khan K, Karim F, Ganga Y, Bernstein M, Jule Z, Reedoy K, et al. . Omicron BA.4/BA.5 escape neutralizing immunity elicited by BA.1 infection. Nat Commun (2022) 13:4686. doi: 10.1038/s41467-022-32396-9</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41467-022-32396-9</ArticleId><ArticleId IdType="pmc">PMC9364294</ArticleId><ArticleId IdType="pubmed">35948557</ArticleId></ArticleIdList></Reference><Reference><Citation>Chalkias S, Harper C, Vrbicky K, Walsh SR, Essink B, Brosz A. Et al. a bivalent omicron-containing booster vaccine against covid-19. N Engl J Med (2022) 387:1279&#x2013;91. doi:&#xa0;10.1056/NEJMoa2208343</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJMoa2208343</ArticleId><ArticleId IdType="pmc">PMC9511634</ArticleId><ArticleId IdType="pubmed">36112399</ArticleId></ArticleIdList></Reference><Reference><Citation>Notarte KI, Catahay JA, Velasco JV, Pastrana A, Ver AT, Pangilinan FC, et al. . Impact of COVID-19 vaccination on the risk of developing long-COVID and on existing long-COVID symptoms: A systematic review. EClinicalMedicine (2022) 53:101624. doi: 10.1016/j.eclinm.2022.101624</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.eclinm.2022.101624</ArticleId><ArticleId IdType="pmc">PMC9417563</ArticleId><ArticleId IdType="pubmed">36051247</ArticleId></ArticleIdList></Reference><Reference><Citation>Temsah MH, Alenezi S, Alarabi M, Aljamaan F, Alhasan K, Assiri R, et al. . Healthcare workers&#x2019; SARS-CoV-2 omicron variant uncertainty-related stress, resilience, and coping strategies during the first week of the world health organization&#x2019;s alert. Int J Environ Res Public Health (2022) 19:1944. doi: 10.3390/ijerph19041944</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijerph19041944</ArticleId><ArticleId IdType="pmc">PMC8872197</ArticleId><ArticleId IdType="pubmed">35206135</ArticleId></ArticleIdList></Reference><Reference><Citation>Khan NH, Hassan S, Bahader S, Fatima S, Zaidi SMIH, Virk R, et al. . How daily obstacles affect frontline healthcare professionals&#x2019; mental health during omicron: A daily diary study of handwashing behavior. Int J Environ Res Public Health (2022) 19:8748. doi: 10.3390/ijerph19148748</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijerph19148748</ArticleId><ArticleId IdType="pmc">PMC9320559</ArticleId><ArticleId IdType="pubmed">35886597</ArticleId></ArticleIdList></Reference><Reference><Citation>Taquet M, Sillett R, Zhu L, Mendel J, Camplisson I, Dercon Q, et al. . Neurological and psychiatric risk trajectories after SARS-CoV-2 infection: an analysis of 2-year retrospective cohort studies including 1&#x2008;284&#x2008;437 patients. Lancet Psychiatry (2022) 9:815&#x2013;27. doi: 10.1016/S2215-0366(22)00260-7</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S2215-0366(22)00260-7</ArticleId><ArticleId IdType="pmc">PMC9385200</ArticleId><ArticleId IdType="pubmed">35987197</ArticleId></ArticleIdList></Reference><Reference><Citation>Cameron JI, Chu LM, Matte A, Tomlinson G, Chan L, Thomas C, et al. . One-year outcomes in caregivers of critically ill patients. N Engl J Med (2016) 374:1831&#x2013;41. doi: 10.1056/NEJMoa1511160</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJMoa1511160</ArticleId><ArticleId IdType="pubmed">27168433</ArticleId></ArticleIdList></Reference><Reference><Citation>Dale CM, Carbone S, Istanboulian L, Fraser I, Cameron JI, Herridge MS, et al. . Support needs and health-related quality of life of family caregivers of patients requiring prolonged mechanical ventilation and admission to a specialised weaning centre: A qualitative longitudinal interview study. Intensive Crit Care Nurs (2020) 58:102808. doi: 10.1016/j.iccn.2020.102808</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.iccn.2020.102808</ArticleId><ArticleId IdType="pubmed">32115334</ArticleId></ArticleIdList></Reference><Reference><Citation>Grande G, Rowland C, van den Berg B, Hanratty B. Psychological morbidity and general health among family caregivers during end-of-life cancer care: A retrospective census survey. Palliat Med (2018) 32:1605&#x2013;14. doi: 10.1177/0269216318793286</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/0269216318793286</ArticleId><ArticleId IdType="pmc">PMC6238177</ArticleId><ArticleId IdType="pubmed">30130458</ArticleId></ArticleIdList></Reference><Reference><Citation>
World Health Organization . WHO coronavirus (COVID-19) dashboard (2022). Available at: https://covid19.who.int (Accessed September 16, 2022).</Citation></Reference><Reference><Citation>Woolf K, Gogoi M, Martin CA, Papineni P, Lagrata S, Nellums LB, et al. . Healthcare workers&#x2019; views on mandatory SARS-CoV-2 vaccination in the UK: A cross-sectional, mixed-methods analysis from the UK-REACH study. EClinicalMedicine (2022) 46:101346. doi: 10.1016/j.eclinm.2022.101346</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.eclinm.2022.101346</ArticleId><ArticleId IdType="pmc">PMC8923694</ArticleId><ArticleId IdType="pubmed">35308309</ArticleId></ArticleIdList></Reference><Reference><Citation>
World Health Organization . Strategic preparedness, readiness and response plan to end the global COVID-19 emergency in 2022 (2022). Available at: https://www.who.int/publications/i/item/WHO-WHE-SPP-2022.1 (Accessed September 16, 2022).</Citation></Reference><Reference><Citation>Maringer Y, Nelde A, Schroeder SM, Schuhmacher J, H&#xf6;rber S, Peter A, et al. . Durable spike-specific T-cell responses after different COVID-19 vaccination regimens are not further enhanced by booster vaccination. Sci Immunol (2022):eadd3899. doi:&#xa0;10.1126/sciimmunol.add3899</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/sciimmunol.add3899</ArticleId><ArticleId IdType="pmc">PMC9798886</ArticleId><ArticleId IdType="pubmed">36318037</ArticleId></ArticleIdList></Reference><Reference><Citation>Kumar S, Patel A, Lai L, Chakravarthy C, Valanparambil R, Reddy ES, et al. . Structural insights for neutralization of omicron variants BA.1, BA.2, BA.4, and BA.5 by a broadly neutralizing SARS-CoV-2 antibody. Sci Adv (2022) 8:eadd2032. doi:&#xa0;10.1126/sciadv.add2032</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/sciadv.add2032</ArticleId><ArticleId IdType="pmc">PMC9534492</ArticleId><ArticleId IdType="pubmed">36197988</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>